News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,043 Results
Type
Article (63132)
Company Profile (296)
Press Release (665615)
Section
Business (211628)
Career Advice (2345)
Deals (36203)
Drug Delivery (83)
Drug Development (84004)
Employer Resources (173)
FDA (16405)
Job Trends (15454)
News (357160)
Policy (33756)
Tag
Academia (2895)
Africa (871)
Alliances (52221)
Alzheimer's disease (1206)
Approvals (16331)
Arizona (187)
Artificial intelligence (71)
Asia (40462)
Australia (7046)
Bankruptcy (357)
Best Places to Work (11571)
Biosimilars (63)
Biotechnology (203)
C2C Services and Suppliers (81747)
California (1817)
Canada (913)
Cancer (415)
Career advice (1953)
Cell therapy (125)
China (140)
Clinical research (65204)
Collaboration (139)
Colorado (72)
Compensation (73)
Connecticut (71)
COVID-19 (2660)
Cystic fibrosis (75)
Data (229)
Diabetes (81)
Diagnostics (6182)
Drug pricing (63)
Earnings (84701)
Employer resources (149)
Europe (90413)
Events (111973)
Executive appointments (141)
FDA (16606)
Florida (255)
Funding (140)
Gene therapy (92)
GLP-1 (541)
Government (4506)
Healthcare (19366)
Hotbed/Location (496113)
Illinois (263)
Indiana (146)
Infectious disease (2688)
Inflammatory bowel disease (91)
Interviews (399)
IPO (16444)
Job creations (3989)
Job search strategy (1677)
Kansas (97)
Layoffs (418)
Legal (8106)
Lung cancer (95)
Manufacturing (88)
Maryland (386)
Massachusetts (1476)
Medical device (13325)
Medtech (13330)
Mergers & acquisitions (19599)
Metabolic disorders (252)
Michigan (123)
Minnesota (220)
Neuroscience (1352)
New Jersey (554)
New York (572)
NextGen Class of 2024 (6790)
Non-profit (4819)
North Carolina (623)
Northern California (803)
Obesity (151)
Ohio (104)
Opinion (189)
Patents (66)
Pennsylvania (570)
People (58501)
Pharmaceutical (66)
Phase I (20255)
Phase II (28598)
Phase III (21301)
Pipeline (103)
Postmarket research (2915)
Preclinical (9129)
Press Release (70)
Rare diseases (130)
Real estate (6437)
Recruiting (65)
Regulatory (22058)
Research institute (2607)
Resumes & cover letters (387)
South America (1234)
Southern California (734)
Startups (3810)
Texas (229)
United States (8405)
Vaccines (507)
Washington State (250)
Weight loss (134)
Date
Today (104)
Last 7 days (666)
Last 30 days (2257)
Last 365 days (38117)
2024 (26338)
2023 (41047)
2022 (52341)
2021 (56960)
2020 (55649)
2019 (48477)
2018 (36603)
2017 (33827)
2016 (33819)
2015 (40442)
2014 (34313)
2013 (30471)
2012 (32086)
2011 (32455)
2010 (31074)
729,043 Results for "leidos biomedical research inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
The Jackson Laboratory and LG AI Research partner to pioneer biomedical advancements
The Jackson Laboratory and LG AI Research signed a partnership agreement creating an alliance between JAX’s longstanding expertise in biomedical research and data analysis and LG’s AI research and product development prowess.
March 11, 2024
·
4 min read
Business
Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference
September 5, 2024
·
1 min read
Drug Development
Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce the Journal of Biomedical Research and Environmental Sciences
February 6, 2024
·
7 min read
Impact Fusion International Inc. Announces the Commencement of a Research Project with Southern University Agricultural and Research Center (SUARC)
Impact Fusion International Inc. (OTC Pink: IFUS) The Company is pleased to announce that a research project with the Southern University Agricultural and Research Center (SUARC) has begun.
May 13, 2024
·
4 min read
Lone Star Bio
TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing
TFF Pharmaceuticals, Inc. today announced that the government will be advancing several next-generation medical countermeasures (MCMs) formulated with its Thin Film Freezing technology into advanced preclinical testing.
May 23, 2024
·
5 min read
BioMidwest
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting
Clearside Biomedical, Inc. announced that multiple oral presentations were delivered at the Clinical Trials at the Summit Meeting on June 8, 2024 in Park City, Utah.
June 12, 2024
·
7 min read
Pharm Country
Celularity Inc. to Host Investor and Analyst Research & Development Day
Celularity Inc. announced today it will host an on-site and virtual Investor and Analyst Research & Development Day.
April 22, 2024
·
4 min read
Press Releases
Vista BioMedical(TM), Inc. Introduces VPAATH(C), an AI-Based Program that Identifies Individual High Risk, High Utilizing Patients Using Social Determinants of Health Factors
July 31, 2024
·
4 min read
Rosalind Franklin University Helix 51 Biomedical Incubator Marks Fifth Anniversary, Rapid Expansion
NORTH CHICAGO, ILLINOIS, May 15, 2024 — Rosalind Franklin University’s Helix 51 biomedical incubator, the only one of its kind in Lake County, Illinois, celebrated its fifth year of...
May 15, 2024
·
2 min read
Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development and commercialization of scientifically compelling assets from research universities and medical centers, announced today that its Scientific Co-founder, Jack A. Elias, MD, co-authored new findings in the peer-reviewed journal Immunity that detail the mechanisms behind the role of chitinase 3-like-1 (CHI3L1) in the growth of triple negative breast cancer.
December 5, 2023
·
9 min read
1 of 72,905
Next